Should low-risk DCIS lose the cancer label? An evidence review

BACKGROUND: Population mammographic screening for breast cancer has led to large increases in the diagnosis and treatment of ductal carcinoma in situ (DCIS). Active surveillance has been proposed as a management strategy for low-risk DCIS to mitigate against potential overdiagnosis and overtreatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Tara, Semsarian, Caitlin R., Barratt, Alexandra, Parker, Lisa, Pathmanathan, Nirmala, Nickel, Brooke, Bell, Katy J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175360/
https://www.ncbi.nlm.nih.gov/pubmed/37074481
http://dx.doi.org/10.1007/s10549-023-06934-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175360/
https://www.ncbi.nlm.nih.gov/pubmed/37074481
http://dx.doi.org/10.1007/s10549-023-06934-y

Ejemplares similares